ZEMBRACESYMTOUCH
How top Indian drug makers like Sun Pharma, Glenmark are building a brands business in the USWhile the market opportunities to sell brands appear optimistic, that road is less treaded by Indian companies and obvious challenges can l...
Dr Reddy's migraine injection enters US marketDr Reddy's Laboratories (DRL) today said its acute migraine treatment injection ZembraceSymTouch is now commercially available in the US ma...
Dr Reddy’s goes beyond generic products, gets nod for two branded drugsThe approvals have come at a time when Indian drug companies are facing the FDA’s ire for non-compliance of good manufacturing process.
Dr Reddy's Lab shares gain over 3% on USFDA nod for productThe stock gained 3.21 per cent to settle at Rs 3,103.60 on BSE. Intra-day, it rose 3.58 per cent to Rs 3,115.
Dr Reddy's gets USFDA nod for migraine injectionThe company has received an approval from the US Food and Drug Administration (USFDA) for ZembraceSymTouch injection, DRL said in a stateme...
Load More